SCHEMBL6284260

SCHEMBL6284260

CSc1cc(C)nc(SC)c1NC(=O)Oc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.46
MAPT P10636 7/20 0.46
KDM4E B2RXH2 5/20 0.46
SOAT1 P35610 6/20 0.44
NPSR1 Q6W5P4 3/20 0.42
RAB9A P51151 2/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP1A2 P05177 2/20 0.41
GAA P10253 3/20 0.41
HPGD P15428 2/20 0.41
TRPV1 Q8NER1 1/20 0.41
PPARG P37231 1/20 0.41
HTT P42858 1/20 0.41
NCOA2 Q15596 1/20 0.41
NCOA1 Q15788 1/20 0.41
PORCN Q9H237 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NPC1 O15118 2/20 0.40
ALOX12 P18054 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8811614 0.88 POLB (0.46) ALDH1A1MAPTKDM4ENPSR1RAB9A
SCHEMBL8807557 0.86 POLB (0.43) ALDH1A1MAPTKDM4ENPSR1RAB9A
SCHEMBL9056446 0.85 ALDH1A1 (0.47) ALDH1A1MAPTKDM4ENPSR1RAB9A
SCHEMBL6280609 0.83 ALDH1A1 (0.47) ALDH1A1MAPTKDM4ENPSR1RAB9A
SCHEMBL6279618 0.82 MAPT (0.43) ALDH1A1MAPTKDM4ENPSR1RAB9A
SCHEMBL9000602 0.79 GRM5 (0.46) ALDH1A1MAPTKDM4ESOAT1NPSR1
SCHEMBL8807498 0.79 ALDH1A1 (0.46) ALDH1A1MAPTKDM4ENPSR1RAB9A
SCHEMBL9000628 0.79 SOAT1 (0.45) MAPTSOAT1NPSR1RAB9AHSD17B10
SCHEMBL3994864 0.78 SOAT1 (0.40) SOAT1GAAHTTMEN1KMT2A
SCHEMBL32667998 0.77 CYP1A2 (0.50) ALDH1A1SOAT1RAB9ACYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6969711-B2 Cyclic diamine compounds and medicine containing the same KOWA COMPANY, LTD. (JP) 2005-11-29 US disclosed
US-20040038987-A1 Novel cyclic diamine compounds and medicine containing the same KOWA COMPANY, LTD. (JP) 2004-02-26 US disclosed
WO-1994026738-A1 N'-HETEROCYCLYL-N-BENZOFURANYL UREA DERIVATIVES AND THEIR ANALOGS AS ACAT INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038987-A1 Novel cyclic diamine compounds and medicine containing the same LCAT, ACAT2, ACAT1 ALDH1A1 307/4885MAPT 1164/4885KDM4E 1460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.